Agilent Technologies Inc (NYSE:A) Shares Bought by First Hawaiian Bank

First Hawaiian Bank raised its stake in shares of Agilent Technologies Inc (NYSE:A) by 15.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 11,733 shares of the medical research company’s stock after buying an additional 1,585 shares during the period. First Hawaiian Bank’s holdings in Agilent Technologies were worth $1,001,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of A. WealthStone Inc. acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at $31,000. Whittier Trust Co. of Nevada Inc. grew its position in Agilent Technologies by 185.5% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 471 shares of the medical research company’s stock valued at $36,000 after buying an additional 306 shares during the period. Nelson Van Denburg & Campbell Wealth Management Group LLC purchased a new position in Agilent Technologies in the second quarter valued at $37,000. Doyle Wealth Management purchased a new position in Agilent Technologies in the second quarter valued at $37,000. Finally, NuWave Investment Management LLC raised its position in shares of Agilent Technologies by 1,184.1% in the third quarter. NuWave Investment Management LLC now owns 565 shares of the medical research company’s stock worth $42,000 after acquiring an additional 521 shares during the period.

In related news, VP Mark Doak sold 8,016 shares of the firm’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $84.50, for a total transaction of $677,352.00. Following the completion of the transaction, the vice president now directly owns 142,017 shares in the company, valued at approximately $12,000,436.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Michael R. Mcmullen sold 24,636 shares of Agilent Technologies stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $80.00, for a total value of $1,970,880.00. Following the completion of the transaction, the chief executive officer now directly owns 332,121 shares of the company’s stock, valued at $26,569,680. The disclosure for this sale can be found here. Insiders have sold a total of 80,652 shares of company stock valued at $6,657,846 in the last ninety days.

NYSE:A opened at $87.99 on Wednesday. The company’s 50-day moving average is $84.09 and its two-hundred day moving average is $76.29. Agilent Technologies Inc has a 1-year low of $65.35 and a 1-year high of $88.32. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.53 and a quick ratio of 1.21. The firm has a market capitalization of $27.17 billion, a price-to-earnings ratio of 28.29, a PEG ratio of 2.05 and a beta of 1.42.

Agilent Technologies (NYSE:A) last posted its earnings results on Monday, November 25th. The medical research company reported $0.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.86 by $0.03. Agilent Technologies had a return on equity of 20.13% and a net margin of 20.74%. The company had revenue of $1.37 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter last year, the firm earned $0.81 earnings per share. The firm’s quarterly revenue was up 5.6% compared to the same quarter last year. As a group, equities analysts anticipate that Agilent Technologies Inc will post 3.41 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be issued a $0.18 dividend. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.16. This represents a $0.72 annualized dividend and a dividend yield of 0.82%. The ex-dividend date of this dividend is Monday, December 30th. Agilent Technologies’s dividend payout ratio is currently 23.15%.

Several brokerages have recently weighed in on A. Barclays reduced their target price on Agilent Technologies from $78.00 to $76.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 9th. Citigroup initiated coverage on shares of Agilent Technologies in a research note on Monday, January 6th. They issued a “neutral” rating and a $85.00 price target on the stock. Needham & Company LLC started coverage on shares of Agilent Technologies in a report on Friday, January 3rd. They issued a “buy” rating and a $77.00 price target for the company. JPMorgan Chase & Co. upped their price objective on shares of Agilent Technologies from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 26th. Finally, Stifel Nicolaus started coverage on shares of Agilent Technologies in a research report on Thursday, November 14th. They set a “hold” rating and a $85.00 price objective for the company. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $84.57.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Story: Trade War

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply